Nomura Holdings
IMVT icon

Nomura Holdings’s Immunovant IMVT Stock Holding History

Nomura Holdings’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$398K Buy
+16,011
New +$415K ﹤0.01% 1436
2025
Q4 		– Sell
-30,000
Closed -$484K – 2023
2025
Q3 		$484K Buy
+30,000
New +$486K ﹤0.01% 1609
2024
Q2 		– Sell
-25,708
Closed -$731K – 1876
2024
Q1 		$831K Buy
+25,708
New +$938K ﹤0.01% 1155

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Nomura Holdings's IMVT Position: Q1 2026 in Review

Nomura Holdings opened a new position in Immunovant (IMVT) in Q1 2026: 16,011 shares worth $398K. The stake represents ﹤0.01% of the portfolio and ranks #1436 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in IMVT as recently as Q3 2025.

Nomura Holdings first reported a position in IMVT in Q1 2024 and has held it in 3 quarters since. The position peaked at $831K in Q1 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Nomura Holdings held 16,011 shares of Immunovant worth $398K as of Q1 2026.
  • Immunovant was a new Nomura Holdings position in Q1 2026.
  • Immunovant made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1436 holding.
  • Nomura Holdings first reported a position in Immunovant in Q1 2024 and has held it in 3 quarters since.
  • Nomura Holdings's Immunovant position peaked at $831K in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.